Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cream may soothe diabetic foot dryness

NCT ID NCT06997718

Symptom relief Sponsor: Pierre Fabre Dermo Cosmetique Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a moisturizing cream (RV5075A-MF6793) on 62 adults with controlled diabetes who had dry, cracked feet. Participants applied the cream or a comparison product twice daily for 28 days. Researchers measured skin dryness, fissure healing, itching, pain, and quality of life. The goal was to see if the cream could improve foot skin comfort and hydration.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RV5075A-MF6793 (a moisturizing cream)
What this could lead to
If it works, this cream could help soothe dry, cracked feet and improve comfort for people with diabetes.
What could go wrong
This is a small, early exploratory study with only 62 people. It compares two creams, not a placebo, so results may not show clear benefit. The condition is not life-threatening.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

62 people

The number who actually took part.

Started

Feb 2025

Finished

Nov 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Main Inclusion criteria: * Gender: Male/Female; * Age: 18 to 75 years old; * Presenting skin phototype between I and IV according to the Fitzpatrick phototyping scale; * Presenting controlled type 1 or 2 diabetes; * Presenting xerosis intensity on feet is rated as 6 according to the Xerosis Assessment Scale (XAS). Main Non-inclusion criteria: * Subject with uncontrolled diabetes and/or with diabetes complications * Subjects with any foot condition or medical history liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational products according to the investigator's assessment * Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational products according to the investigator's assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot xerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot xerosis

Contacts and locations

Locations

  • Inovapotek

    Porto, 4200-135, Portugal